Pharmacological Properties of Diclofenac Sodium and Its Metabolites

Publisher Website
Google Scholar
Abstract
Diclofenac sodium (Voltaren) is a non-steroid anti-inflammatory agent of a new chemical structure, which in animal experiments shows a high degree of antiinflammatory, analgesic, and antipyretic activity in various pharmacological models. It inhibits prostaglandin biosynthesis in vitro and in vivo, and this inhibitory effect at least partly explains the mechanism of action of the preparation. In animal experiments diclofenac sodium is characterised by a broad therapeutic range. Also, its gastrointestinal tolerability is better than that of other highly effective non-steroid anti-inflammatory agents. Two of the metabolites produced during the biotransformation of diclofenac sodium in man are also biologically active. The activity of these two metabolites, however, is very much weaker than that of unchanged diclofenac sodium and is comparable to that of phenylbutazone.